Navigation Links
EntreMed Presents Results for Panzem(R) NCD Phase 2 Ovarian Cancer Study
Date:10/24/2007

Results Demonstrate Activity in Advanced Disease

ROCKVILLE, Md., Oct. 24 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the presentation of results for its Phase 2, open-label study for Panzem(R) NCD (2ME2 or 2-methoxyestradiol) in patients with ovarian cancer. The results were presented by Dr. Daniela Matei, principal investigator for the study representing the Hoosier Oncology Group, at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics being held this week in San Francisco, California.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

Data from the Phase 2 study demonstrate that Panzem(R) NCD, administered as a single agent in patients with platinum refractory epithelial ovarian cancer, resulted in one patient with a confirmed partial response of their CA- 125. Five patients, out of the 18 patients enrolled, achieved stable disease lasting greater than three months. Panzem(R) NCD was well tolerated and no significant neuropathy, myelosuppression or thromboembolic side effects were reported. Three patients remained on study for more than 6 months and two of these patients are still on study.

Data from in vitro studies demonstrated that 2ME2 has activity against a variety of ovarian carcinoma cell lines including those resistant to other chemotherapeutic agents. In preclinical models of ovarian cancer, 2ME2 has shown a significant survival advantage compared to animals that did not receive treatment. Furthermo
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
2. IDM Pharma Presents Preliminary Results of Melanoma Vaccine Clinical Trial
3. Living Liver Donor Who Saved Life of Mother-in-law Represents Cedars-Sinai in Rose Parade
4. Childrens Hospital Boston Presents at the Society for Adolescent Medicine Annual Meeting
5. Monogram Presents Results of First ETag Breast Cancer Studies
6. Novagali Pharma Presents Phase III Clinical Trial of Vekacia(R) for Vernal Keratoconjunctivitis
7. Experimental treatment for Ebola Virus Shows promising results in mice
8. Hormone Deficiency Results In Miscarriage
9. Gleevec gets hopeful results
10. Breast Implants May Interfere With The Interpretation Of Mammogram Results
11. DNA Testing For More Accurate Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... new study finds that women treated for breast can...y have dense breasts. Published in the December 15...of the American Cancer Society, the study,s result...breasts may benefit from additional therapies foll...dies indicate that women with dense breast tissue ...
(Date:11/8/2009)..., PHILADELPHIA, Nov. 8 ...lauds the prevention and wellness provisions in th...e. ,, "With passage of this bill, the House tak...orting important insurance reforms and moving our ...e sick to one that focuses on keeping people healt...
(Date:11/8/2009)..., Higher Costs and Crushing Taxes Nail Nation,s J...SNewswire/ -- In response to U.S. House passage of...& Entrepreneurship Council (SBE Council) presi... statement: ,, "Make no mistake, those voting ...ators with higher costs and crushing taxes and pen...
(Date:11/8/2009)... Freeze-drying of biopharmac...ssissauga, Ontario facility. , ...mas Wellner, President and CEO of Therapure Biopha...n delivery of a commercial scale pharmaceutical gr...ale freeze drying (lyophilization) available for c...
(Date:11/8/2009)..., Nation,s largest network of Hispanic health ad...are reform in 2009 ,, WASHINGTON, Nov. 7 /PRNe...epresentatives showed they have heard the voice of...th Care for America Act. Now the Senate must deliv...alth care reform," said Dr. Jane L. Delgado, Presi...
Breaking Medicine News(10 mins):Health News:Breast density associated with increased risk of cancer recurrence 2Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2
...0 Jobs, HARRISBURG, Pa., Dec. 28 /PRNewswire-USNe...e Williamsport Hospital and Medical Center campus,... a $12.5 million grant,from the commonwealth, the ...ears -- for debt service to the Lycoming County In...
...,Acquisition Corp. ("Echo" or the "Company") (OTC ...unced at its special meeting of stockholders today... provide stockholders,additional time to consider ...us previously mailed to Echo stockholders.,The Ech...
...ission,to provide service, support and hope to all... America (LFA) submitted comments today to Commiss...stration (SSA), regarding a,proposed change to the...be submitted 5 days,before an administrative heari...
...helped for at least a decade , , FRIDAY, D...ly and safely corrects severe myopia for at least ...pia, which is caused by excessive curving of the e...from some degree of nearsightedness. , Laser surge...
...Year,s as the,"world championship" of weight loss,...nd promises. For millions of well-intentioned diet... and, ultimately,disappointment., (See video fro...mber,by Harris Interactive(R) on behalf of GlaxoSm...
... A review published in Dermatologic Therapy revea... procedures in the same way as women but require h...here has recently become a growing interest in cos... often require more units of Botox than women whic...
Other Medicine News:Health News:Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4, 2008 2Health News:Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4, 2008 3Health News:Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4, 2008 4Health News:Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4, 2008 5Health News:Lupus Foundation of America Urges Social Security Administration Not to Adopt Proposed 5-Day Rule 2Health News:Laser Surgery Can Correct Nearsightedness 2Health News:VIDEO from Medialink and GlaxoSmithKline: Really Think You Can 'Lose 30 Pounds in 30 Days?' 2
(Date:11/6/2009)...all/ -- Recession in domestic and international ma...care Products in the first quarter of fiscal year ...es pushed Allied into a loss for the quarter. The...egative 9 cents per share, compared to a net profi...er share. ,, Sales fell about 21 percent in th...
(Date:11/6/2009)...e-FirstCall/ -- DUSA Pharmaceuticals, Inc.(®)...developing and marketing Levulan(®) Photodyna...tients with common skin conditions, announced that... will present a corporate overview at the Merriman...mber 10, 2009 at 10:00 a.m. ET at the Hotel Sofite...
(Date:11/6/2009)...-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:...y, announced today that Paul Bisaro, Watson,s pres... overview and update of the Company,s business at ...e on Wednesday, November 11, 2009 at 12:00 pm East... webcast live and can be accessed on Watson Pharma...
Breaking Medicine Technology:Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6Martek Announces Second Quarter 2009 Financial Results 47844 1Martek Announces Second Quarter 2009 Financial Results 47844 2Martek Announces Second Quarter 2009 Financial Results 47844 3Martek Announces Second Quarter 2009 Financial Results 47844 4Martek Announces Second Quarter 2009 Financial Results 47844 5Martek Announces Second Quarter 2009 Financial Results 47844 6Martek Announces Second Quarter 2009 Financial Results 47844 7Martek Announces Second Quarter 2009 Financial Results 47844 8Martek Announces Second Quarter 2009 Financial Results 47844 9Martek Announces Second Quarter 2009 Financial Results 47844 10Martek Announces Second Quarter 2009 Financial Results 47844 11Martek Announces Second Quarter 2009 Financial Results 47844 12Speaker Pelosi Call Your Science Advisor 21 12454 1Ambry Genetics Announces Launch of Chromosomal Microarray to Offer Whole Genome Analysis 47837 1Ambry Genetics Announces Launch of Chromosomal Microarray to Offer Whole Genome Analysis 47837 2Ambry Genetics Announces Launch of Chromosomal Microarray to Offer Whole Genome Analysis 47837 3
... announced,today that it is planning a European La...io-Thoracic Surgeons (EACTS) meeting in Geneva,Swi...w.newscom.com/cgi-bin/prnh/20061027/DEF004LOGO ...27/CLTU043LOGO ) A summary of the European Clini...Left Ventricular Assist System (LVAS) will be pres...
...ic Natural Physical Environment, MIAMI, Sept. 5 ...ntation as the treatment of choice for type 1 diab...nts often need a re-infusion of islet,cells after ...r pancreas is,needed to provide the fragile islet ...at the Diabetes Research Institute,( http://www.di...
Other Medicine Technology:Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September 2Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells 2
...t two-stage, oil-sealed, rotary vane vacuum pumps ...pplications. Each pump comes complete with a GBORK...ter (EMF-10). The GBORK allows the user to apply f...ng oil. The EMF10 filter the exhaust to keep envir...
...rformance for all vacuum requirements. A 3 positio...o suit all applications. The large, sideview sight...l levels at a glance. The VLP series of pumps is d...ncentrating and freeze drying systems for maximum ...
...et, compact, efficient vacuum source developed spe...e design and TEFLON®/ETFE coated vapor path of...ced maintenance. Unique features include a TEFLON ..., and a 1-liter post-pump solvent recovery vessel ...
...t two-stage, oil-sealed, rotary vane vacuum pumps ...pplications. Each pump comes complete with a GBORK...ter (EMF-10). The GBORK allows the user to apply f...ng oil. The EMF10 filter the exhaust to keep envir...
Medicine Products: